These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 9692346)
41. Inhibition of leukotriene C4 and B4 release by human eosinophils with the new 5-lipoxygenase inhibitor 6-hydroxy-2(4-sulfamoylbenzylamino)-4,5,7-trimethylbenzothiazo le hydrochloride. Fukuda T; Numao T; Akutsu I; Toda M; Motojima S; Makino S Arzneimittelforschung; 1995 Sep; 45(9):1002-4. PubMed ID: 7488299 [TBL] [Abstract][Full Text] [Related]
42. Role of lipoxygenases in breast cancer. Natarajan R; Nadler J Front Biosci; 1998 Jun; 3():E81-8. PubMed ID: 9616130 [TBL] [Abstract][Full Text] [Related]
43. Central role of arachidonate 5-lipoxygenase in the regulation of cell growth and apoptosis in human prostate cancer cells. Ghosh J; Myers CE Adv Exp Med Biol; 1999; 469():577-82. PubMed ID: 10667385 [No Abstract] [Full Text] [Related]
44. Effects of eicosanoid synthesis inhibitors on the in vitro growth and prostaglandin E and leukotriene B secretion of a human breast cancer cell line. Earashi M; Noguchi M; Kinoshita K; Tanaka M Oncology; 1995; 52(2):150-5. PubMed ID: 7854776 [TBL] [Abstract][Full Text] [Related]
45. MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells. Lim JY; Oh JH; Jung JR; Kim SM; Ryu CH; Kim HT; Jeun SS J Neurooncol; 2010 May; 97(3):339-46. PubMed ID: 19862483 [TBL] [Abstract][Full Text] [Related]
46. Leukotriene biosynthesis inhibition by aryl and aroyl substituted naphthoquinones. Roland DM; Macchia WM; Grim KS; Kimble EF; White DH; Kowalski TJ Agents Actions; 1991 Sep; 34(1-2):145-7. PubMed ID: 1665288 [TBL] [Abstract][Full Text] [Related]
48. Biological Evaluation of Lysionotin: a Novel Inhibitor of 5-Lipoxygenase for Anti-glioma. Shao XX; Chen C; Liu J; Li QJ; He S; Qi XH; Fu XJ; Wang ZG Chin J Integr Med; 2024 Sep; 30(9):826-834. PubMed ID: 38990479 [TBL] [Abstract][Full Text] [Related]
49. Influence of ethanol on in vitro growth of human mammary carcinoma cell line MCF-7. Przylipiak A; Rabe T; Hafner J; Przylipiak M; Runnebaum R Arch Gynecol Obstet; 1996; 258(3):137-40. PubMed ID: 8781701 [TBL] [Abstract][Full Text] [Related]
50. 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Fischer AS; Metzner J; Steinbrink SD; Ulrich S; Angioni C; Geisslinger G; Steinhilber D; Maier TJ Br J Pharmacol; 2010 Oct; 161(4):936-49. PubMed ID: 20860670 [TBL] [Abstract][Full Text] [Related]
51. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells. Dittmann KH; Mayer C; Rodemann HP; Petrides PE; Denzlinger C Leuk Res; 1998 Jan; 22(1):49-53. PubMed ID: 9585079 [TBL] [Abstract][Full Text] [Related]
52. Use of a continuous assay of oxygen consumption to evaluate the pharmacology of 5-lipoxygenase inhibitors. Breton J; Keller P; Chabot-Fletcher M; Hillegass L; DeWolf W; Griswold D Prostaglandins Leukot Essent Fatty Acids; 1993 Dec; 49(6):929-37. PubMed ID: 8140120 [TBL] [Abstract][Full Text] [Related]
53. Effects of piroxicam and esculetin on the MDA-MB-231 human breast cancer cell line. Noguchi M; Earashi M; Minami M; Miyazaki I; Tanaka M; Sasaki T Prostaglandins Leukot Essent Fatty Acids; 1995 Nov; 53(5):325-9. PubMed ID: 8596770 [TBL] [Abstract][Full Text] [Related]
54. Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines. Gáti I; Bergström M; Csóka K; Muhr C; Carlsson J Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):117-24. PubMed ID: 2117290 [TBL] [Abstract][Full Text] [Related]
55. Modulation of cellular proliferation and induction of apoptosis in a human lymphoma cell line after treatment with selective lipoxygenase inhibitors. Anderson KM; Ondrey FG; Harris JE Adv Exp Med Biol; 1999; 469():563-8. PubMed ID: 10667383 [No Abstract] [Full Text] [Related]
56. A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA array. Anderson KM; Alrefai WA; Bonomi PA; Anderson CA; Dudeja P; Harris JE Anticancer Res; 2000; 20(4):2433-9. PubMed ID: 10953307 [TBL] [Abstract][Full Text] [Related]
57. Impact of MK-886 on H2O2 generation by human neutrophils and cell degranulation. Gorudko IV; Timoshenko AV Biochemistry (Mosc); 2001 Mar; 66(3):290-4. PubMed ID: 11333152 [TBL] [Abstract][Full Text] [Related]
58. Comparative studies of steroidogenesis inhibitors (econazole, ketoconazole) on human breast cancer MCF-7 cell proliferation by growth experiments, thymidine incorporation and flow cytometric DNA analysis. Najid A; Ratinaud MH Tumori; 1991 Oct; 77(5):385-90. PubMed ID: 1781035 [TBL] [Abstract][Full Text] [Related]
59. MK 886 functions as a radiomimetic agent: genomic responses related to oxidative stress, the cell cycle, proliferation and programmed cell death in Panc-1 cells. Anderson KM; Alrefai W; Anderson C; Bonomi P; Harris J Adv Exp Med Biol; 2002; 507():451-6. PubMed ID: 12664625 [No Abstract] [Full Text] [Related]
60. The mode of cell death in H-358 lung cancer cells cultured with inhibitors of 5-lipoxygenase or the free radical spin trap, NTBN. Ou D; Bonomi P; Jao W; Jadko S; Harris JE; Anderson KM Cancer Lett; 2001 May; 166(2):223-31. PubMed ID: 11311496 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]